Helix BioPharma Corp News - HBP

Helix BioPharma Corp. Announces Fiscal First Quarter 2019 Results

RICHMOND HILL, Ontario, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), a an...

Helix Biopharma Corp. Closes First Tranche of Private Placement

RICHMOND HILL, Ontario, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix”...

Helix BioPharma Corp. Provides Strategic Update on L-DOS47 Clinical Program

RICHMOND HILL, Ontario, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), an...

Helix BioPharma Corp. to initiate new L-DOS47 clinical program in pancreatic cancer

RICHMOND HILL, Ontario, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP...

Helix BioPharma Corp. Closes Private Placement

RICHMOND HILL, Ontario, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix”...

Helix BioPharma Corp. Announces Fiscal 2018 Year-End Results

RICHMOND HILL, Ontario, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), an...

Helix BioPharma Corp. Extends Period to Exercise Warrants

RICHMOND HILL, Ontario, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: HBP) ("Helix" or...

Helix BioPharma Corp. and Moffitt Cancer Center extend collaboration on immunotherapy, including study of L-DOS47 with PD-1/P...

RICHMOND HILL, Ontario, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP...

Helix BioPharma Corp. Initiates Enrollment of the Second Last Cohort in U.S. Combination Treatment Study of Its Lung Cancer D...

RICHMOND HILL, Ontario, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: HBP) ("Helix" or...

Helix BioPharma Corp. collaborator ProMab Biotechnologies Publishes Paper on Multiple Myeloma CAR-T

RICHMOND HILL, Ontario, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP), (FSE:HBP...

Helix BioPharma Corp. Closes Private Placement

RICHMOND HILL, Ontario, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP)(FSE:HBP) (“Helix”...

Helix BioPharma Corp. collaborator ProMab Biotechnologies to present at the CAR-TCR Summit 2018 in Boston

RICHMOND HILL, Ontario, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP...

Helix BioPharma Corp. Closes Private Placement

RICHMOND HILL, Ontario, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix”...

Helix BioPharma Corp. Completes Fourth Dosing Cohort and Initiates Enrollment of the Next Cohort in U.S. Combination Treatmen...

RICHMOND HILL, Ontario, July 25, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FSE:HBP) ("Helix...

Helix BioPharma Corp. Closes Private Placement

RICHMOND HILL, Ontario, July 09, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FSE:HBP) (“Helix”...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Helix BioPharma Corp (HBP)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

HBP News

Helix BioPharma Corp. Announces Fiscal First Quarter 2019 Results

Helix Biopharma Corp. Closes First Tranche of Private Placement

Helix BioPharma Corp. Provides Strategic Update on L-DOS47 Clinical Program

Helix BioPharma Corp. to initiate new L-DOS47 clinical program in pancreatic cancer

Helix BioPharma Corp. Closes Private Placement

Helix BioPharma Corp. Announces Fiscal 2018 Year-End Results

Helix BioPharma Corp. Extends Period to Exercise Warrants

Helix BioPharma Corp. and Moffitt Cancer Center extend collaboration on immunotherapy, including study of L-DOS47 with PD-1/P...

Helix BioPharma Corp. Initiates Enrollment of the Second Last Cohort in U.S. Combination Treatment Study of Its Lung Cancer D...

Helix BioPharma Corp. collaborator ProMab Biotechnologies Publishes Paper on Multiple Myeloma CAR-T

Helix BioPharma Corp. Closes Private Placement

Helix BioPharma Corp. collaborator ProMab Biotechnologies to present at the CAR-TCR Summit 2018 in Boston

Helix BioPharma Corp. Closes Private Placement

Helix BioPharma Corp. Completes Fourth Dosing Cohort and Initiates Enrollment of the Next Cohort in U.S. Combination Treatmen...

Helix BioPharma Corp. Closes Private Placement

HBP Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Helix BioPharma Corp (HBP) News

Helix BioPharma Corp (HBP)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

HBP News

Helix BioPharma Corp. Announces Fiscal First Quarter 2019 Results

Helix Biopharma Corp. Closes First Tranche of Private Placement

Helix BioPharma Corp. Provides Strategic Update on L-DOS47 Clinical Program

Helix BioPharma Corp. to initiate new L-DOS47 clinical program in pancreatic cancer

Helix BioPharma Corp. Closes Private Placement

Helix BioPharma Corp. Announces Fiscal 2018 Year-End Results

Helix BioPharma Corp. Extends Period to Exercise Warrants

Helix BioPharma Corp. and Moffitt Cancer Center extend collaboration on immunotherapy, including study of L-DOS47 with PD-1/P...

Helix BioPharma Corp. Initiates Enrollment of the Second Last Cohort in U.S. Combination Treatment Study of Its Lung Cancer D...

Helix BioPharma Corp. collaborator ProMab Biotechnologies Publishes Paper on Multiple Myeloma CAR-T

Helix BioPharma Corp. Closes Private Placement

Helix BioPharma Corp. collaborator ProMab Biotechnologies to present at the CAR-TCR Summit 2018 in Boston

Helix BioPharma Corp. Closes Private Placement

Helix BioPharma Corp. Completes Fourth Dosing Cohort and Initiates Enrollment of the Next Cohort in U.S. Combination Treatmen...

Helix BioPharma Corp. Closes Private Placement

HBP Discussion

Your Recent History